Cost remains a major barrier, with monthly prices often exceeding $1,000 without insurance coverage
Ozeki Y, Masaki T, Kamata A, Miyamoto S, Yoshida Y, Okamoto M, et al
The availability of both weekly injectable and daily oral formulations further broadens its reach across diverse patient and prescriber segments
This dual mechanism of action is why tirzepatide is classified as a GIP/GLP-1 receptor agonist rather than simply a GLP-1 receptor agonist
Patients with type two diabetes can take semaglutide (Wegovy, Ozempic, Rybelsus) to lose weight, lower blood sugar levels and reduce the risk of major cardiovascular events such as heart attacks and strokes
Phase II Clinical Trials: Efinopegdutide (Merck/Johnson & Johnson/Hanmi Hanma), VK2735 (Viking Therapeutics), BGM0504 (BrightGene), Pemvidutide (Altimmune/Spitfire Pharma), AMG133 (Amgen), Dapiglutide (Zealand Pharma), etc